BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1618230)

  • 1. Lymphoma imaging with a new technetium-99m labelled antibody, LL2.
    Murthy S; Sharkey RM; Goldenberg DM; Lee RE; Pinsky CM; Hansen HJ; Burger K; Swayne LC
    Eur J Nucl Med; 1992; 19(6):394-401. PubMed ID: 1618230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial clinical results with technetium-99m-labeled LL2 monoclonal antibody fragment in the radioimmunodetection of B-cell lymphomas.
    Baum RP; Niesen A; Hertel A; Adams S; Kojouharoff G; Goldenberg DM; Hör G
    Cancer; 1994 Feb; 73(3 Suppl):896-9. PubMed ID: 8306276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved staging of B-cell non-Hodgkin's lymphoma patients with 99mTc-labeled LL2 monoclonal antibody fragment.
    Blend MJ; Hyun H; Kozloff M; Levi H; Mills GQ; Gasparini M; Buraggi G; Hughes L; Pinsky CM; Goldenberg DM
    Cancer Res; 1995 Dec; 55(23 Suppl):5764s-5770s. PubMed ID: 7493343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of radioimmunoscintigraphy of non-Hodgkin's lymphoma with radiolabelled LL2 monoclonal antibody, LymphoSCAN: preliminary results.
    Gasparini M; Bombardieri E; Tondini C; Maffioli L; Hughes L; Burraggi GL; Goldenberg DM
    Tumori; 1995; 81(3):173-8. PubMed ID: 7571023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 67Ga citrate versus 99mTc-labeled LL2-Fab' (anti-CD22) fragments in the staging of B-cell non-Hodgkin's lymphoma.
    Becker WS; Behr TM; Cumme F; Rössler W; Wendler J; Kern PM; Gramatzki M; Kalden JR; Goldenberg DM; Wolf FG
    Cancer Res; 1995 Dec; 55(23 Suppl):5771s-5773s. PubMed ID: 7493344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99Tcm-LL1: a potential new bone marrow imaging agent.
    Juweid M; Dunn RM; Sharkey RM; Rubin AD; Hansen HJ; Goldenberg DM
    Nucl Med Commun; 1997 Feb; 18(2):142-8. PubMed ID: 9076770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunolocalization of transitional cell carcinoma of the bladder with intravesically administered technetium-99m labelled HMFG1 monoclonal antibody.
    Malamitsi J; Zorzos J; Varvarigou AD; Archimandritis S; Dassiou C; Skarlos DV; Dimitriou P; Likourinas M; Zizi A; Proukakis C
    Eur J Nucl Med; 1995 Jan; 22(1):25-31. PubMed ID: 7698151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunodetection of colorectal carcinoma using technetium-99m-labeled Fab' fragments of the IMMU-4 anti-carcinoembryonic antigen monoclonal antibody.
    Moffat FL; Vargas-Cuba RD; Serafini AN; Casillas VJ; Morillo G; Benedetto P; Robinson DS; Ardalan B; Manten HD; Clark KC
    Cancer; 1994 Feb; 73(3 Suppl):836-45. PubMed ID: 8306268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
    Goldenberg DM; Goldenberg H; Sharkey RM; Higginbotham-Ford E; Lee RE; Swayne LC; Burger KA; Tsai D; Horowitz JA; Hall TC
    Cancer Res; 1990 Feb; 50(3 Suppl):909s-921s. PubMed ID: 2297741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technetium-99m monoclonal antibody fragment (Fab) scintigraphy in the evaluation of small cell lung cancer: a preliminary report.
    Morris JF; Krishnamurthy S; Antonovic R; Duncan C; Turner FE; Krishnamurthy GT
    Int J Rad Appl Instrum B; 1991; 18(6):613-20. PubMed ID: 1660451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-targeted immunodetection in glioma patients: tumour localization and single-photon emission tomography imaging of [99mTc]PnAO-biotin.
    Paganelli G; Magnani P; Zito F; Lucignani G; Sudati F; Truci G; Motti E; Terreni M; Pollo B; Giovanelli M
    Eur J Nucl Med; 1994 Apr; 21(4):314-21. PubMed ID: 8005155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tc-99m LL-2 Fab' monoclonal antibody imaging in acquired immune deficiency syndrome-related lymphoma.
    Kramer EL; Volm M; Donahue B; Wasserheit C; Chapnick J; Sanger J; Koslow M
    Cancer; 1997 Dec; 80(12 Suppl):2469-77. PubMed ID: 9406697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody.
    Goldenberg DM; Horowitz JA; Sharkey RM; Hall TC; Murthy S; Goldenberg H; Lee RE; Stein R; Siegel JA; Izon DO
    J Clin Oncol; 1991 Apr; 9(4):548-64. PubMed ID: 2066752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunodetection of non-small cell lung cancer using technetium-99m-anticarcinoembryonic antigen IMMU-4 Fab' fragment. Preliminary results.
    Kramer EL; Noz ME; Liebes L; Murthy S; Tiu S; Goldenberg DM
    Cancer; 1994 Feb; 73(3 Suppl):890-5. PubMed ID: 8306275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of non-Hodgkin's lymphoma with radiolabeled murine, chimeric, or humanized LL2, an anti-CD22 monoclonal antibody.
    Juweid M; Sharkey RM; Markowitz A; Behr T; Swayne LC; Dunn R; Hansen HJ; Shevitz J; Leung SO; Rubin AD
    Cancer Res; 1995 Dec; 55(23 Suppl):5899s-5907s. PubMed ID: 7493367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 99mTc-CD19 monoclonal antibody is not useful for imaging of B cell non-Hodgkin's lymphoma.
    Vervoordeldonk SF; Heikens J; Goedemans WT; Merle PA; von dem Borne AE; van Royen EA; Slaper-Cortenbach IC; van Oers RH
    Cancer Immunol Immunother; 1996 Jun; 42(5):291-6. PubMed ID: 8706051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive detection of atherosclerotic lesions by 99mTc-based immunoscintigraphic targeting of proliferating smooth muscle cells.
    Narula J; Petrov A; Pak KY; Ditlow C; Chen F; Khaw BA
    Chest; 1997 Jun; 111(6):1684-90. PubMed ID: 9187194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging of colorectal carcinoma with technetium-99m radiolabeled Fab' fragments.
    Podoloff DA; Patt YZ; Curley SA; Kim EE; Bhadkamkar VA; Smith RE
    Semin Nucl Med; 1993 Apr; 23(2):89-98. PubMed ID: 8511605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of technetium 99m-labeled monoclonal antibody in the management of melanoma patients.
    Blend MJ; Ronan SG; Salk DJ; Gupta TK
    J Clin Oncol; 1992 Aug; 10(8):1330-7. PubMed ID: 1634923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.